Relation between cytokines and Helicobacter pylori in gastric cancer

Helicobacter

Volumn 6, Issue 2, 2001, Pages 116-124

  Yamaoka, Yoshio ^a   Kodama, Tadashi ^b   Kita, Masakazu ^b   Imanishi, Jiro ^b   Kashima, Kei ^b   Graham, David Y ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Gastric cancer; Helicobacter pylori; Interleukin 6; Interleukin 8

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ADVANCED CANCER; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CYTOKINE RELEASE; EARLY CANCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER;

CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0034952052     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5378.2001.00017.x     Document Type: Article

References (34)

1. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model
2. Helicobacter pylori infection induces gastric cancer in mongolian gerbils
3. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils
4. Acute Helicobacter pylori infection: Clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations
5. Immune and inflammatory responses to Helicobacter pylori infection
6. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa
7. Induction of various cytokines and development of severe mucosal inflammation by cagA gene-positive Helicobacter pylori strains
8. Chemokines in the gastric mucosa in Helicobacter pylori infection
9. Relation between clinical presentation, Helicobacter pylori density, interleukin-1β and -8 production and cagA status
10. Serum interleukin-6 levels reflect disease status of gastric cancer
11. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma
12. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
13. The biology of interleukin-6
14. Biological and clinical aspects of interleukin 6
15. Immuno-suppressive cytokines (IL-10, TGF-β) genes expression in human gastric carcinoma tissues
16. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis
17. Part 1. Clinical, surgical, and conclusive findings
18. The two histological main types of gastric carcinomas: Diffuse and so-called intestinal type of carcinoma
19. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori
20. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome
21. Host response to H. pylori: Molecular analysis of cytokine gene expression
22. Interleukin-8. A corneal factor that induces neo-vascularization
23. Interleukin-8 as a macrophage-derived mediator of angiogenesis
24. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
25. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas
26. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma
27. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma
28. Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication
29. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies
30. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma
31. Cytokine levels (IL-6 and IFN-γ), acute phase response and nutritional status as prognostic factors in lung cancer
32. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer
33. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma
34. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat